Late Breaking News ORION-1, Professor Kausik Ray

Prof Kausik Ray discusses the ORION 1 study with inclisiranПодробнее

Inhibition of PCSK9 Synthesis Via RNA InterferenceПодробнее

WHF Roadmap for Cholesterol | Prof Kausik RayПодробнее

Professor Kausik Ray - PCSK9 inhibition – have we reached the limits of lipid lowering and outcome?Подробнее

The cholesterol numbers you need to know (at any age) – with Professor Kausik RayПодробнее

New findings from the ORION-11 study - Professor Kausik K. RayПодробнее

Prof. Kausik Ray: Late Breaking Session at EAS Congress 2019Подробнее

Residual cardiovascular risk a role for PCSK9 inhibition | Professor Kausik RayПодробнее

Prof Kausik Ray: How will FOURIER impact FH care?Подробнее

Kausik Ray about the EAS FH studies collaborationПодробнее

ACC AHA guidelines: Where do you new treatments fit | Professor Kausik RayПодробнее

Interview with Prof. Kausik Ray - latest study on FH prevalence globally May 2020Подробнее

Kausik Ray: The ODYSSEY Insulin TrialsПодробнее

Professor Kausik Ray - The global burden of diabetes.Подробнее

Prof Kausik Ray gives an analysis of the PCSK9 inhibitor outcomes studiesПодробнее

ORION-1Подробнее

Results of BETonMACE with Kausik RayПодробнее

AHA 2019 : Results Of The BETonMACE Trial — Prof Kausik K RayПодробнее

ESC 2018: CLEAR Harmony - Prof Kausik RayПодробнее